Resumen
Objetivo: Analizar el manejo del lipedema, desde el diagnóstico hasta el tratamiento, considerando las estrategias disponibles en la atención a la salud y los desafíos para su abordaje adecuado. Revisión bibliográfica: El lipedema es una condición crónica caracterizada por una distribución anormal del tejido adiposo subcutáneo, frecuentemente confundida con obesidad o linfedema. Su fisiopatología incluye factores hormonales, genéticos y metabólicos, progresando a través de etapas distintas con un impacto significativo en la calidad de vida física, emocional y social de las pacientes. En la atención primaria, el diagnóstico precoz es fundamental, aunque limitado por la falta de conocimiento y recursos. Las estrategias terapéuticas incluyen drenaje linfático, terapia de compresión y apoyo psicológico, siendo necesario el derivamiento para tratamientos avanzados, como la liposucción. La telemedicina y la creación de guías específicas son destacadas como herramientas para mejorar el manejo. Consideraciones finales: La atención primaria desempeña un papel crucial en el reconocimiento temprano y la coordinación del cuidado de pacientes con lipedema. Invertir en la capacitación de profesionales, desarrollar protocolos nacionales y fortalecer enfoques multidisciplinarios son estrategias esenciales para mejorar los resultados clínicos y la calidad de vida de las pacientes.
Referencias
ALOSAIMI K, et al. Characteristics and clinical features of patients with lipedema in Saudi Arabia: A cross-sectional comprehensive assessment. Plastic and Reconstructive Surgery. Global Open, 2024; 12(9): 6173.
AMATO ACM, et al. Ultrasound criteria for lipedema diagnosis. Phlebology, 2021; 36(8): 651–658.
ANNE WARREN PELED A, et al. Lipedema: diagnostic and management challenges. International Journal of Women’s Health, 2016; 8: 389–395.
ARTEMOVA AS, et al. Lipedema: a professional community’s view. Rossiiskii Meditsinskii Zhurnal: Organ Ministerstva Zdravookhraneniia RSFSR, 2023; 29(6): 467–474.
BUCK DW e HERBST KL. Lipedema: A relatively common disease with extremely common misconceptions. Plastic and Reconstructive Surgery. Global Open, 2016; 4(9): 1043.
BUSO G, et al. Lipedema: A call to action! Obesity (Silver Spring, Md.), 2019; 27(10): 1567–1576.
CÂMARA B, et al. Lipedema: Um problema subdiagnosticado. Gazeta Médica, 2024; 255–256.
CARBALLEIRA BRAÑA A e POVEDA CASTILLO J. The advanced care study: Current status of lipedema in Spain, A descriptive cross-sectional study. International Journal of Environmental Research and Public Health, 2023; 20(17).
CHACHAJ A, et al. Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University, 2024; 33(12): 1367–1377.
ERDEN Y, et al. A surge of interest: Analysing the increased public interest in lipedema using Google Trends. Phlebology, 2024.
ESEN ÖZDEMIR E, et al. YouTube as a source of information on lipedema: Property, quality, and reliability assessment. Lymphatic Research and Biology, 2023; 21(4): 403–409.
ESMER M e SCHINGALE FJ. Can physical therapy techniques slow down the progression of lipedema? Lymphatic Research and Biology, 2024; 22(6): 267–270.
FORNER-CORDERO I, et al. Prevalence of clinical manifestations and orthopedic alterations in patients with lipedema: A prospective cohort study. Lymphology, 2022; 54(4).
FORNER-CORDERO I, et al. Update in the management of lipedema. International Angiology: A Journal of the International Union of Angiology, 2021; 40(4): 345–357.
HALK AB e DAMSTRA RJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology, 2017; 32(3): 152–159.
HERBST KL, et al. Standard of care for lipedema in the United States. Phlebology, 2021; 36(10): 779–796.
JANTSCH AG, et al. Residency training in family medicine and its impact on coordination and continuity of care: An analysis of referrals to secondary care in Rio de Janeiro. BMJ Open, 2022; 12(2): 51515.
KATZER K, et al. Lipedema and the potential role of estrogen in excessive adipose tissue accumulation. International Journal of Molecular Sciences, 2021; 22(21): 11720.
KRUPPA P, et al. Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Frontiers in Immunology, 2023; 14.
KRUPPA P, et al. Lipedema-pathogenesis, diagnosis, and treatment options. Deutsches Arzteblatt International, 2020; 117(22–23): 396–403.
LEACH J. A family doctor has a holistic approach. BMJ (Clinical Research Ed.), 2022; 532.
NANKAM PAN, et al. Is subcutaneous adipose tissue expansion in people living with lipedema healthier and reflected by circulating parameters? Frontiers in Endocrinology, 2022; 13.
POOJARIII A, et al. Lipedema: Insights into morphology, pathophysiology, and challenges. Biomedicines, 2022; 10(12): 3081.
RUIZ-SILVA C, et al. Treatment of lipedema using cryolipolysis associated with microcurrents. IOSR Journal of Dental and Medical Sciences, 2024; 23(10): 5–12.
STANGE KC, et al. The role of primary care in improving population health. The Milbank Quarterly, 2023; 101(S1): 795–840.
WHITEBIRD RR, et al. Care coordination in primary care: Views of clinicians and clinic leaders. Journal of Nursing Care Quality, 2025; 40(1): 90–97.
WITTE T, et al. Water-jet-assisted liposuction for the treatment of lipedema: Standardized treatment protocol and results of 63 patients. Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS, 2020; 73(9): 1637–1644.
